Back to search

Ireland· IE-PA-EU/1/18/1331/001

Luxturna 5 × 1012 vector genomes/mL concentrate and solvent for solution for injection

A voretigene neparvovec product containing voretigene neparvovec, registered in Ireland by Novartis Ireland Limited. The same ATC class is registered in 13 of our 19 countries.

ATC S01XA27

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedLuxturna 5 × 1012 vector genomes/mL c…ATCS01XA27REGISTER NO.IE-PA-EU/1/18/1331/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Voretigene neparvovec is registered in 13 of 19 countries.

Countries holding a registration under ATC S01XA27 (voretigene neparvovec), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Voretigene neparvovec · ATC S01XA27

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
VORETIGENE NEPARVOVEC
Manufacturer
Novartis Ireland Limited
Country
Ireland (IE)
ATC code
S01XA27
ATC class
Voretigene neparvovec
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/18/1331/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/170a389c-c3b1-457f-8d72-76fa8cb7a35a
GET /v1/drugs/170a389c-c3b1-457f-8d72-76fa8cb7a35a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate and solvent for solution for injection",
  "routes": [
    "Subretinal use"
  ],
  "source": "hpra",
  "atc_all": [
    "S01XA27"
  ],
  "strength": null,
  "pa_number": "EU/1/18/1331/001",
  "substances": [
    "VORETIGENE NEPARVOVEC"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "22/11/2018",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about voretigene neparvovec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.